Ophthalmology

Ophthalmology includes companies developing therapies, devices, and diagnostics for diseases of the eye, including retinal disorders, glaucoma, dry eye, and surgical vision care. This page groups businesses exposed to both therapeutic and procedure-driven eye care markets.

Why watch Ophthalmology

This page combines a company index, a watch action, and the newest relevant feed items in one place so readers can monitor a biotech theme without scanning each company one by one.

Latest Ophthalmology news

The latest feed items from companies currently grouped under Ophthalmology.

1. 01
   2026-11-06 12:00 EST

   OCULOcular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

   Source: Ocular Therapeutix

2. 02
   2026-11-05 21:30 EST

   TARSTarsus to Participate in Upcoming Investor Conferences

   Source: Tarsus Pharmaceuticals

3. 03
   2026-11-05 21:05 EST

   SGHTSight Sciences to Present at Two Upcoming Investor Conferences

   Source: Sight Sciences

4. 04
   2026-11-05 13:00 EST

   SGHTSight Sciences Announces CMS Establishment of a Practice Expense Supply Code for TearCare SmartLids

   Source: Sight Sciences

5. 05
   2026-11-05 13:00 EST

   LCTXLineage Cell Therapeutics to Report Third Quarter 2026 Financial Results and Provide Business Update on November 12, 2026

   Source: Lineage Cell Therapeutics

6. 06
   2026-11-04 21:05 EST

   SGHTSight Sciences Reports Third Quarter 2026 Financial Results and Raises Full-Year 2026 Revenue Guidance

   Source: Sight Sciences

7. 07
   2026-11-03 21:05 EST

   OCSOculis Reports Q3 2026 Financial Results and Builds Momentum Toward Multiple Upcoming Pipeline Catalysts

   Source: Oculis

8. 08
   2026-11-03 21:05 EST

   TARSTarsus Reports Third Quarter 2026 Financial Results

   Source: Tarsus Pharmaceuticals

9. 09
   2026-11-03 21:05 EST

   IRIXIridex to Report Third Quarter 2026 Financial Results on November 17, 2026

   Source: IRIDEX

10. 10
    2026-11-02 12:00 EST

    HROWHarrow Launches HarrowRx Platform

    Source: Harrow, Inc.

11. 11
    2026-11-02 12:00 EST

    OCULOcular Therapeutix™ to Report Third Quarter 2026 Financial Results on November 9, 2026

    Source: Ocular Therapeutix

12. 12
    2026-11-02 07:00 EST

    OCSOculis Appoints Experienced Life Sciences Leader Björn Tackenberg, M.D., Ph.D., as Chief Scientific Officer to Advance Neurology Innovation

    Source: Oculis

13. 13
    2026-10-29 20:30 EST

    TARSTarsus to Report Third Quarter 2026 Financial Results on Tuesday, November 3, 2026

    Source: Tarsus Pharmaceuticals

14. 14
    2026-10-29 12:00 EST

    LCTXLineage Provides Update on ReSonance® Program for Hearing Loss

    Source: Lineage Cell Therapeutics

15. 15
    2026-10-29 11:02 EST

    OCGNOcugen to Participate in Upcoming November Investor and Industry Conferences

    Source: Ocugen

16. 16
    2026-10-29 11:00 EST

    OCULOcular Therapeutix™ to Participate in November Investor and Scientific Conferences

    Source: Ocular Therapeutix

17. 17
    2026-10-29 11:00 EST

    KPRXKiora Pharmaceuticals In-Licenses Late-Stage, Oral Neuroprotective Calpain Inhibitor for Central Retinal Artery Occlusion (CRAO) with Planned Expansion into NAION; Asset Completed Phase 3 Clinical Trial in CRAO in Japan

    Source: Kiora Pharmaceuticals

18. 18
    2026-10-29 09:39 EST

    OCSOculis to Feature Privosegtor’s Neuroprotective Potential and Ongoing PIONEER Program at APOIS Congress and CNS Summit

    Source: Oculis

19. 19
    2026-10-28 20:30 EST

    LENZLENZ Therapeutics Reports Third Quarter 2026 Financial Results, Announces Strategic Consumer Marketing Focused Reorganization and CEO Succession

    Source: Lenz Therapeutics Inc

20. 20
    2026-10-28 12:30 EST

    TARSTarsus Pharmaceuticals Appoints Neera Clase as Chief Commercial Officer

    Source: Tarsus Pharmaceuticals

Companies in Ophthalmology

29 companies tagged with Ophthalmology.

Frequently Asked Questions